Tag: ultrasound-BCI

4 articles

Market Moves

Bridge Neurotech raises $13.5 million to build a brain-computer interface without surgery

Bridge Neurotech, a Silicon Valley start-up founded in 2026 by Will Biederman, came out of stealth on 6 October with $13.5 million from General Catalyst, reMind Capital, Sunflower Capital, Scott Sandell and others to build a wearable brain-computer interface that images brain activity with functional ultrasound through the skull. It has signed a multi-year research and development agreement to license Butterfly Network's Ultrasound-on-Chip technology, with payments for technology access and development milestones and commitments to buy Butterfly hardware; the value was not disclosed. Biederman co-founded the ultrasound research group Forest Neurotech, which signed a five-year, $20 million co-development deal with Butterfly in 2023. Forest's other two co-founders, Sumner Norman and Tyson Aflalo, went on to co-found Merge Labs, which signed its own Butterfly licensing deal on 1 September. Bridge's first research study, which is observational, is enrolling healthy adults and adults whose skulls were repaired with PEEK or Longeviti implants in Redwood City, California.

Oct 8

Industry News

Merge Labs picks Butterfly's ultrasound-on-chip for its brain-computer interface build

Merge Labs, the US$252 million OpenAI-backed neural interface startup, has selected Butterfly Network (NYSE:BFLY) as its exclusive ultrasound-on-chip supplier under a multi-year Butterfly Embedded licensing deal announced 1 September 2026. The agreement covers Butterfly's Poseidon Family of Ultrasound-on-Chip for Merge's neural interface development, with upfront payments, milestones, hardware purchase commitments, technology access fees, and future royalties. Financial figures were not disclosed. Butterfly retains the right to license the same technology to other companies in the field. Ultrasound BCI now has a US-listed industrial supply chain.

Sep 1

Market Moves

Delian Capital partner warns of a Chinese BCI bubble

VCBeat, the Chinese healthcare-investment media outlet, published an on-record investor take on the Chinese brain-computer interface sector on 2 August 2026. Delian Capital partner Jiang Donghui framed the sector as at risk of a bubble cycle before maturity, laid out a four-quadrant investment matrix based on demand and technological advancement, and named Chinese BCI companies across invasive, semi-invasive and non-invasive paths. H1 2026 financing alone accounted for approximately 60 per cent of the sector's thirteen-year total.

Aug 2

Market Moves

Gestala closes US$62 million Angel+ round for ultrasound BCI, opens Shanghai NeuroAI headquarters

Gestala (格式塔科技), a Chinese non-invasive ultrasound brain-computer interface company led by founder and CEO Phoenix Peng, announced on 3 July 2026 that it had closed a US$62 million Angel+ financing round and formally opened a Shanghai NeuroAI headquarters. The company is the third Chinese ultrasound BCI startup to disclose funding within ten days, alongside Sisen Technology (1 July 2026) and Huachao Shenkong.

Jul 3